secwatch.observer — SEC 8-K summary
======================================

Issuer:     NextCure, Inc. (NXTC)
CIK:        0001661059
Form:       8-K
Filed at:   2025-02-03T23:59:59+00:00
Accession:  0001558370-25-000603
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

NextCure receives Nasdaq bid price deficiency notice; has until July 30, 2025 to regain compliance
--------------------------------------------------------------------------------

- Nasdaq notified NextCure that its closing bid price was below $1.00 for 30 consecutive business days.
- Company has 180-day grace period ending July 30, 2025 to meet the $1.00 minimum bid for 10 consecutive days.
- If not compliant, NextCure may seek an additional 180-day extension if it meets other listing standards.
- The company is evaluating options including a reverse stock split; delisting risk remains.
- No immediate effect on trading; stock continues trading on Nasdaq Global Select Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661059/000155837025000603/0001558370-25-000603-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661059/000155837025000603/nxtc-20250131x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-000603

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer